发明名称 |
RETINOIC ACID RECEPTOR ANTAGONISTS AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS AND USES THEREOF |
摘要 |
Compounds, compositions and methods are provided for selectively activating chaperone-mediated autophagy (CMA), protecting cells from oxidative stress, proteotoxicity and lipotoxicity, and/or antagonizing activity of retinoic acid receptor alpha (RARα) in subjects in need thereof. |
申请公布号 |
US2015166492(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201414566762 |
申请日期 |
2014.12.11 |
申请人 |
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY |
发明人 |
CUERVO ANA MARIA;GAVATHIOTIS EVRIPIDIS;XIN QISHENG;DAS BHASKAR C. |
分类号 |
C07D265/36;C07D413/10;G01N33/68;C07C279/22 |
主分类号 |
C07D265/36 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound having the structure of formula (I) wherein R1 and R2 of formula (I) are independently H or methyl; R4, R5, R6 and R7 of formula (I) are independently, H, hydroxyl, halogen or alkyl, or R8 and R5 or R6 of formula (I) together form a 5- or 6-membered heteroaryl; and R8 of formula (I) is C≡N, 5- or 6-membered heteroaryl,where a represents the point of attachment of R8 to the 6-membered ring and Q is a 5- or 6-membered heteroaryl or Q and C═O of R8 together form a 5- or 6-membered heteroaryl, or R8 and R5 or R6 of formula (I) together form a 5- or 6-membered heteroaryl, where each heteroaryl can be optionally substituted with one or more of CN, ═O, NH2 and phenyl;
or a pharmaceutically acceptable salt thereof. |
地址 |
BRONX NY US |